𝔖 Bobbio Scriptorium

✦ LIBER ✦

Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers

✍ Scribed by Dean L. Mann; Christina M. Celluzzi; Kim G. Hankey; Kristina M. Harris; Ryuko Watanabe; Kenichiro Hasumi

Book ID: 111399334
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 294 KB
Volume: 1174
Category: Article
ISSN: 0890-6564
DOI: 10.1111/j.1749-6632.2009.04934.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dendritic cell-based combined immunother

Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives

✍ Takashi MORISAKI; Kotaro MATSUMOTO; Hideya ONISHI; Hideo KUROKI; Eishi BABA; Aki 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

256 Intratumoral injection of dendritic

256 Intratumoral injection of dendritic cells engineered to secrete interleukin-12 by adenovirus in patients with primary and secondary liver cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Modifications of plasma lipids, lipoprot

Modifications of plasma lipids, lipoproteins and apolipoproteins in advanced cancer patients treated with recombinant interleukin-2 and autologous lymphokine-activated killer cells

✍ C.L. Malmendier; J-F. Lontie; J.P. Sculier; D.Y. Dubois 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 660 KB

In vivo induction of HPV 16 specific cyt

In vivo induction of HPV 16 specific cytotoxic ctl and T-helper immunity in patients with advanced cervical cancer using autologous dendritic cells (dc) pulsed with tumour lysate as a potential anti-cancer vaccine

✍ Adams, M.; de Jong, A.; Navabi, H.; Lippetz, C.; Jasani, B.; Man, S.; Fiander, A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Pretreatment neutrophil to lymphocyte ra

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy

✍ Yanwen Yao, Dongmei Yuan, Hongbing Liu, Xiaoling Gu… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 247 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB